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Rolf Luft, a giant in medicine and a pio-
neer in the fields of diabetes, endocri-
nology, and mitochondrial diseases,
left us on the 22nd of May, 2007. We
have lost not only a great scientist
and physician but also a highly gifted,
generous, and warm-hearted mentor,
teacher, and human being.
Rolf Luft was born June 29, 1914 in
Stockholm to a poor working-class
Jewish family. Though there was not
enough money to pay for his educa-
tion, Rolf’s brilliance was evident
even as a young man, and his studies
were funded by scholarships. He re-
ceived his MD at the age of 26, and
four years later he completed his PhD
with a thesis on Cushing’s syndrome
and the effects of cortisone. In 1945
Rolf was instrumental in the establish-
ment of endocrinology as a discipline
in Sweden, and he played a key role
in the founding of the Swedish Endo-
crine Society. He later served as pro-
fessor of endocrinology at Karolinska
Institutet; he was the first professor of
endocrinology in Europe. Rolf Luft
also started the first national
program for diabetes care,
and later he founded a WHO
center for education in diabe-
tes. His scientific activities
also included serving as the
president of the International
Diabetes Federation (1973–
1979), a member of the Nobel
Assembly at Karolinska Institu-
tet (1961–1980), and the presi-
dent of the Nobel Committee
for physiology or medicine
(1976–1979). He was also
a member of several other
Swedish national and interna-
tional organizations and asso-
ciations including the Swedish
Royal Academy of Sciences,
The Royal College of Physi-
cians, the National Academy
of Sciences, the American
Academy of Arts and Sciences,
and the Finnish Society of Arts
and Letters. Rolf was an honor-
able member of most interna-
tional diabetes organizations in the
world and honorable doctor at many
universities. Over his lifetime he re-
ceived 40 international awards and
medals.
Rolf always had a creativemind, and
very early he understood that it was
imperative to have a research labora-
tory in close proximity to the clinic. In
the early 1940s he established a small
hormone diseases clinic connected to
a small research laboratory. Thus, the
translational medicine concept was
introduced. In 1990 a modern world-
leading, state-of-the-art laboratory for
cell biology and molecular biology
within the diabetes and endocrinology
fields, The Rolf Luft Research Center
for Diabetes and Endocrinology, was
inaugurated at the Karolinska Univer-
sity Hospital. The activity of this labo-
ratory has steadily increased, and the
Rolf Luft ResearchCenter is now a cor-
nerstone of Karolinska Institutet.
Rolf’s research was forward thinking
andcreativeandalways focusedon the
endocrine and metabolic diseases to
which he devoted his career. In 1941
Rolf showed that androgens were pro-
duced in women by the adrenals. In
1946 a grant from the Family Wallen-
berg Foundation enabled him to study
endocrinology in the US with the aim
of introducing this discipline to Swe-
den. While abroad, Rolf demonstrated
that adrenocorticotropic hormone
(ACTH) treatmentcould improvesymp-
toms in patients with rheumatism. Dur-
ing a particularly productive period in
1949–1951, Rolf studied the ‘‘body
spaces,’’ ‘‘lean body mass,’’ and the
metabolic effects of hormones, espe-
cially ACTH, deoxycorticosterone ace-
tate (DOCA), cortisone, and growth
hormone, work which resulted in the
award of several PhD theses under
his supervision.During thenextdecade
or so, he continued his innovative
work, introducing hypophysectomy as
a treatment for severe diabetic retinop-
athy and advanced metastasic breast
cancer. This was based on the hypoth-
esis that the reduction of growth hor-
mone secretion could improve the
treatment of these conditions,
and indeed positive results
were published in several pa-
pers. During this time, Rolf
also demonstrated that human
growthhormonehadadiabeto-
genic effect in healthy, diabetic,
and also hypophysectomized
diabetic patients.
1958 was a very important
year for Rolf Luft. With help
from a large donation from the
FamilyWallenberg Foundation,
he established the first Endo-
crine Clinic at Karolinska Insti-
tutet and Karolinska University
Hospital in Stockholm. Rolf’s
work over the next few years
pioneered a new, highly impor-
tant and very exciting field:
mitochondrial medicine. Rolf
performed the first studies on
human mitochondria in a pa-
tient who exhibited excessive
sweating and other metabolic
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mitochondria. This syndrome, named
the Rolf Luft disease, was the first
biochemically defined mitochondrial
disease.
In 1967, together with Errol Cerasi,
Rolf published an important hypothe-
sis within the diabetes field entitled
‘‘‘What is inherited–what is added’
hypothesis for the pathogenesis of
diabetes mellitus’’ (Cerasi and Luft,
1967). They put forth the idea that first
phase insulin response to glucose is
inherited, and that further impairment
of this response underlies the develop-
ment of type 2 diabetes mellitus. Rolf’s
contributions also included the dem-
onstration in 1974–1975, with Suad
Efendic, that somatostatin was pro-
duced not only in the hypothalamus
but also in the endocrine part of the
pancreas, the islets of Langerhans.
Together they also published the first
studies on the effects of somatostatin
analogs.
Rolf’s scientific work extended be-
yond the laboratory and the hospital;
he also played an important role in
the development of the Swedish phar-
maceutical industry. In 1960 his labo-
ratory produced growth hormone
from pituitaries for the first time, and
production was later established at
the pharmaceutical company Kabi.
Further development led to the pro-
duction of recombinant growth hor-
mone, Genotropine, a leading drug
for Kabi, later to become Pharmacia.
Rolf also, throughout his lifetime, took
a great interest and active part in soci-
etal issues; in the 1960s he was instru-mental in changing Swedish law to
recognize trans-sexuality as a medical
disorder and to allow gender changes.
Undoubtedly, Rolf Luft has played
an important role for Swedish medical
research and, in particular, the re-
search conducted at Karolinska
Institutet. In honor of Rolf, Karolinska
Institutet has established the Rolf Luft
Award, now in its sixth year, given to
world-leading scientists for their semi-
nal discoveries within the fields of dia-
betes and endocrinology. To further
enhance the potential of diabetes
research, in 2004 Rolf created the
Rolf Luft Foundation for Diabetes
Research.
Rolf Luft realized early on that
a good lifestyle is important for a long
and active life. He used to run in the
park close to the hospital every morn-
ing for an hour, and for many years he
participated in the 90 km long ski race
‘‘Vasaloppet.’’ He enjoyed walking in
the mountains and working in the gar-
den of his summer house. Until the age
of 90, he walked daily from his apart-
ment to the Karolinska University
Hospital. Rolf was a renowned chef,
and he used to invite all his young
colleagues, researchers, and friends
for dinners and discussions on Satur-
day afternoons. Rolf’s discoveries
stemmed from endless curiosity and
great interest for the patient and the
ability to see the importance of the
close associations between clinical
and basic research.
Until his death Rolf was a stimulating
and spiritual discussion partner and an
enduring source of wisdom and goodCell Metabolism 6,advice to his younger colleagues.
Rolf was never one to give up; typi-
cally, even when he intellectually un-
derstood that life had come to an
end, he could not accept it emotion-
ally. ‘‘I do not have time to die, yet I still
have so many things left undone..’’
Unfortunately we all must accept that
sooner or later life is over, and all we
can do is to make the most of life, of
every single moment. This is indeed
how Rolf lived, together with his won-
derful wife and life companion Ritva.
After all Rolf had a long, good, and re-
warding life. Naturally we will miss his
presence, but our joyful memories of
him will lead us forward in his spirit.
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